Literature DB >> 230854

Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells.

F Weiland, E Weiland, M Mussgay.   

Abstract

Transplantation of a Moloney sarcoma-virus (MSV-M)-transformed producer cell line (Sac(+)) induced progressively or regressively growing tumours in mice. Progressive growth always occurred after transplantation of an MSV-M non-producer transformant (Sac(-)), whereas the MSV-M released from the producer cells (Sac virus) always induced tumours which regressed. In contrast to the non-producer, the producer transformant Sac(+) as well as Sac virus induced a strong immune response, detected in vitro by cell- and antibody-mediated cytotoxicity assays, and in vivo by transplantation immunity. Implantation of Sac(-) cells led to solid, under-vascularized tumours, consisting histologically of uniform densely packed tumour cells. Sac-virus-induced tumours, however, were very well vascularized and arose by proliferation of different connective-tissue cells. After transplantation of Sac(+) cells, tumours were found to consist of typical tumour cells morphologically similar to Sac(-) cells intermingled with proliferated connective-tissue cells. Cultivation of tumour fragments from Sac(+) and Sac(-) tumours was followed by outgrowth of transformed tumour cells with the properties of the originally implanted cells. Tumour explant cultures from Sac-virus-induced tumours did not lead to growth of stably transformed cells. Co-culture of mouse embryo fibroblasts (MEF) with Sac(+) cells resulted in overgrowth of the transformed cells. Infection of MEF with Sac virus led to transiently transformed cells. It is concluded that Sac(+) cell tumours will resist the strong immune defence mechanisms they induce and grow progressively, if the inoculated cells are able to build up a solid, poorly vascularized nodule in the tissue. This always happens after implantation of 10(6) cells, but only occasionally when fewer cells are inoculated. Sac-virus-induced tumours will always regress owing to the strong immune response. The regression is furthered by the fact that MSV-M infection rarely if ever leads to a stable transformation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230854      PMCID: PMC2010123          DOI: 10.1038/bjc.1979.288

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Pathologic and virologic studies of tumors induced in mice by two strains of murine sarcoma virus.

Authors:  P J Simons; D J McCully
Journal:  J Natl Cancer Inst       Date:  1970-06       Impact factor: 13.506

Review 2.  Viral 'tumor antigens': A novel type of mammalian regulator protein.

Authors:  R Weil
Journal:  Biochim Biophys Acta       Date:  1978-11-17

3.  Generation of new mouse sarcoma viruses in cell culture.

Authors:  U R Rapp; C Todaro
Journal:  Science       Date:  1978-09-01       Impact factor: 47.728

4.  Temperature sensitive mutants of an avian sarcoma virus.

Authors:  K Toyoshima; P K Vogt
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

5.  A quantitative study on transformation of hamster embryo cells in vitro by murine sarcoma viruses (Harvey and Moloney).

Authors:  R C Ting; A V Bader
Journal:  Virology       Date:  1969-10       Impact factor: 3.616

Review 6.  Immunogenicity of tumor antigens.

Authors:  R B Herberman
Journal:  Biochim Biophys Acta       Date:  1977-12-23

7.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

8.  Comparison of murine sarcoma viruses in nonproducer and S + L - -transformed cells.

Authors:  S A Aaronson; R H Bassin; C Weaver
Journal:  J Virol       Date:  1972-04       Impact factor: 5.103

9.  Granulation tissue as a contractile organ. A study of structure and function.

Authors:  G Gabbiani; B J Hirschel; G B Ryan; P R Statkov; G Majno
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma.

Authors:  E Weiland; M Mussgay; F Weiland
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  2 in total

1.  Transformed cell lines derived from progressor Sarcoma virus (Moloney) induced tumors. I. Differences in pathogenicity between C type viruses from producer and helper virus infected nonproducer cells.

Authors:  E Weiland; M Mussgay
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.

Authors:  E Weiland; M Mussgay
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.